Fairmount Funds Management LLC Geron Corp Transaction History

Fairmount Funds Management LLC

  • $615 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$1.75 - $3.44 $11.7 Million - $22.9 Million
6,666,667 New
6,666,667 $22 Million
Q1 2023

May 15, 2023
BUY
$2.14 - $3.4 $15.2 Million - $24.2 Million
7,104,358 New
7,104,358 $15.4 Million

Others Institutions Holding GERN

# of Institutions
275
Shares Held
491M
Call Options Held
1.87M
Put Options Held
690K
View Full List

About GERON CORP

GERN Quotes by TradingView
  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.51B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Fairmount Funds Management LLC Portfolio

Follow Fairmount Funds Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairmount Funds Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email